Could a Six-Month exercise and diet plan shield muscle during melanoma treatment?

NCT ID NCT07761871

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether a six-month program of supervised resistance exercise and personalized nutritional support can help adults with stage II to IV melanoma preserve muscle mass and quality while starting immunotherapy. Participants are randomly assigned to either the exercise and nutrition program alongside standard cancer care, or standard care alone. The study tracks changes in thigh muscle volume, fat infiltration, body composition, fatigue, and treatment tolerance over six months. The goal is to see if this supportive approach can reduce muscle loss and improve outcomes during immunotherapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Structured resistance exercise combined with individualized nutritional support
What this could lead to
If effective, this approach could help melanoma patients on immunotherapy maintain muscle mass and quality, potentially improving treatment tolerance and quality of life.
What could go wrong
This is a small early-stage trial, and results may not apply broadly. The intervention may not significantly change muscle outcomes or clinical results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

melanoma Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institute of Oncology Ljubljana

    RECRUITING

    Ljubljana, 1000, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.